Supplements > Economic Considerations for the Treatment of Opioid and Alcohol Dependence

Supplements - Economic Considerations for the Treatment of Opioid and Alcohol Dependence

June 16, 2011 – Jeffrey D. Dunn, PharmD, MBA, Formulary and Contract Manager, SelectHealth
June 17, 2011 – Saira Jan, PharmD; Patrick Gill, RPh; and Ami S. Borawala, PharmD
June 17, 2011 – William C. Bryson, MD, MPH; K. John McConnell, PhD; P. Todd Korthuis, MD, MPH; and Dennis McCarty, PhD
June 17, 2011 – Onur Baser, MS, PhD; Mady Chalk, PhD; Richard Rawson, PhD; and David R. Gastfriend, MD
June 17, 2011 – Onur Baser, MS, PhD; Mady Chalk, PhD; David A. Fiellin, MD; and David R. Gastfriend, MD
June 16, 2011 – Jeffrey D. Dunn, PharmD, MBA, Formulary and Contract Manager, SelectHealth
June 17, 2011 – Onur Baser, MS, PhD; Mady Chalk, PhD; David A. Fiellin, MD; and David R. Gastfriend, MD
June 17, 2011 – William C. Bryson, MD, MPH; K. John McConnell, PhD; P. Todd Korthuis, MD, MPH; and Dennis McCarty, PhD
June 17, 2011 – Saira Jan, PharmD; Patrick Gill, RPh; and Ami S. Borawala, PharmD
June 17, 2011 – Onur Baser, MS, PhD; Mady Chalk, PhD; Richard Rawson, PhD; and David R. Gastfriend, MD
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.